Trials / Active Not Recruiting
Active Not RecruitingNCT01922440
A Registry for Participants With Chronic Hypoparathyroidism
PARADIGHM (Physicians Advancing Disease Knowledge in Hypoparathyroidism): A Registry for Patients With Chronic Hypoparathyroidism
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,339 (actual)
- Sponsor
- Takeda · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The main aim of this study is to find out the long-term safety and effectiveness profile of recombinant human parathyroid hormone (1-84) (rhPTH\[1-84\]) treatment in participants with chronic hypoparathyroidism under conditions of routine clinical practice. Participants will be treated according to their clinic's standard practice determined by the treating doctors. Each participant will fill out a study questionnaire during a routine doctor visit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | This is a non-interventional study. |
Timeline
- Start date
- 2013-07-30
- Primary completion
- 2034-11-30
- Completion
- 2034-11-30
- First posted
- 2013-08-14
- Last updated
- 2025-09-29
Locations
100 sites across 11 countries: United States, Austria, Canada, Denmark, Germany, Greece, Italy, Norway, Spain, Sweden, United Kingdom
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT01922440. Inclusion in this directory is not an endorsement.